Search
forResearch 10 of 429
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- FDA approves label addition for PDE-5 inhibitor
- 467 Novel selective phosphodiesterase inhibitors promote the adipogenic function of dermal fibroblasts: Implication to treat hair loss
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Adverse effects of common medications on male fertility
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Organic Causes of Erectile Dysfunction in Men Under 40
- Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses
- Smoke water promotes root meristem activity and cell elongation but inhibits root hair growth under phosphorus deficiency in rice
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →